Is CHCR or JNJ a better dividend investment in 2026?

CHCR currently yields 16299974.00% with a 5% 5-year dividend growth rate. JNJ yields 2.13% with 5.8% growth. The better choice depends on your goal: CHCR offers higher current income.

What is the dividend yield difference between CHCR and JNJ?

CHCR has a forward dividend yield of 16299974.00% ($16.30/share annually). JNJ yields 2.13% ($5.20/share annually). The yield gap is 16299971.87 percentage points.

Home › Compare › CHCR vs JNJ

CHCR vs JNJ: Dividend Comparison 2026

CHCR yields 16299974.00% · JNJ yields 2.13%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 CHCR wins by $6.304323781898378e+48M in total portfolio value

INVESTMENT

TIME HORIZON10 years

CHCR

● Live price

16299974.00%

Share price

$0.00

Annual div

$16.30

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$6.304323781898378e+48M

Annual income

$6,304,247,699,510,647,000,000,000,000,000,000,000,000,000,000,000,000,000.00

Full CHCR calculator →

JNJ

Johnson & Johnson

● Live price

2.13%

Share price

$244.44

Annual div

$5.20

5Y div CAGR

28%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.3K

Annual income

$4,689.40

Full JNJ calculator →

Portfolio growth — CHCR vs JNJ

📍 CHCR pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	CHCR	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, CHCR + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

CHCR pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CHCR

Annual income on $10K today (after 15% tax)

$1,385,497,790.00/yr

After 10yr DRIP, annual income (after tax)

$5,358,610,544,584,050,400,000,000,000,000,000,000,000,000,000,000,000,000.00/yr

JNJ

Annual income on $10K today (after 15% tax)

$180.82/yr

After 10yr DRIP, annual income (after tax)

$3,985.99/yr

At 15% tax rate, CHCR beats the other by $5,358,610,544,584,050,400,000,000,000,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CHCR + JNJ for your $10,000?

CHCR: 50%JNJ: 50%

100% JNJ50/50100% CHCR

Portfolio after 10yr

$3.152161890949189e+48M

Annual income

$3,152,123,849,755,324,000,000,000,000,000,000,000,000,000,000,000,000,000.00/yr

Blended yield

100.00%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

CHCR

No analyst data

Altman Z

-71.4

Piotroski

1/9

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

-6.4% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CHCR buys

JNJ buys

No recent congressional trades found for CHCR or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricCHCRJNJ

Forward yield	16299974.00% ✓	2.13%
Annual dividend / share	$16.30 ✓	$5.20
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	28% ✓
Portfolio after 10y	$6.304323781898378e+48M	$30.3K ✓
Annual income after 10y	$6,304,247,699,510,647,000,000,000,000,000,000,000,000,000,000,000,000,000.00 ✓	$4,689.40
Total dividends collected	$6.304318804493443e+48M	$15.4K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: CHCR vs JNJ ($10,000, DRIP)

Year	CHCR Portfolio	CHCR Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$1,630,008,100	$1,629,997,400.00	$10,592	$272.30	+$1630.00M → CHCR
2	$248,310,993,172,119	$248,309,249,063,452.47	$11,289	$357.73	+$248310993.16M → CHCR
3	$35,352,372,711,888,600,000	$35,352,107,019,125,903,000.00	$12,123	$472.89	+$35352372711888.59M → CHCR
4	$4,703,895,210,347,744,700,000,000	$4,703,857,383,308,944,000,000,000.00	$13,141	$629.86	+$4703895210347744256.00M → CHCR
5	$584,942,498,970,756,060,000,000,000,000	$584,937,465,802,880,900,000,000,000,000.00	$14,408	$846.81	+$5.849424989707561e+23M → CHCR
6	$67,980,632,016,017,940,000,000,000,000,000,000	$67,980,006,127,544,040,000,000,000,000,000,000.00	$16,021	$1,151.60	+$6.798063201601794e+28M → CHCR
7	$7,383,694,540,484,102,000,000,000,000,000,000,000,000	$7,383,621,801,207,846,000,000,000,000,000,000,000,000.00	$18,122	$1,588.22	+$7.383694540484103e+33M → CHCR
8	$749,512,305,709,058,000,000,000,000,000,000,000,000,000,000	$749,504,405,155,899,700,000,000,000,000,000,000,000,000,000.00	$20,930	$2,228.20	+$7.49512305709058e+38M → CHCR
9	$71,105,035,262,902,380,000,000,000,000,000,000,000,000,000,000,000	$71,104,233,284,735,270,000,000,000,000,000,000,000,000,000,000,000.00	$24,792	$3,191.91	+$7.110503526290238e+43M → CHCR
10	$6,304,323,781,898,378,000,000,000,000,000,000,000,000,000,000,000,000,000	$6,304,247,699,510,647,000,000,000,000,000,000,000,000,000,000,000,000,000.00	$30,274	$4,689.40	+$6.304323781898378e+48M → CHCR

CHCR vs JNJ: Complete Analysis 2026

CHCR — Stock

Advanzeon Solutions, Inc., through its subsidiary, Pharmacy Value Management Solutions, Inc., administers and operates a sleep apnea program known as SleepMaster Solutions. The company was formerly known as Comprehensive Care Corporation and changed its name to Advanzeon Solutions, Inc. in January 2014. Advanzeon Solutions, Inc. was founded in 1969 and is headquartered in Tampa, Florida. On September 7, 2020, Advanzeon Solutions, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Middle District of Florida.

Full CHCR Calculator →

JNJ — Healthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →

📬

Get this CHCR vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CHCR vs SCHD CHCR vs JEPI CHCR vs O CHCR vs KO CHCR vs MAIN CHCR vs ABBV CHCR vs MRK CHCR vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.